Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?

Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.

Can Ion Emerge as ISRG's Vehicle to Tap Ambulatory Care Growth?

Intuitive Surgical's Ion platform gains traction in ambulatory centers, driving 52% growth as outpatient lung diagnostics accelerate.

High Margins, Lower Price: Is Intuitive Surgical Stock A Buy?

Intuitive Surgical (ISRG) stock deserves your consideration. Why? Because you get monopoly-like high margins for a discounted price.

Can ISRG Continue Its Strong Growth Amid Tariff & Rare Earth Woes?

ISRG's growth momentum faces pressure as tariffs and China's rare earth export curbs threaten margins and supply stability.

ISRG Shares Rise as FDA Clears AI Integration for Ion Platform

Intuitive Surgical shares climb after FDA clears AI-driven upgrades for its Ion platform, boosting precision and efficiency in lung biopsies.

Intuitive Surgical, Inc. (ISRG) to Report Q3 Results: Wall Street Expects Earnings Growth

Intuitive Surgical (ISRG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ISRG Bets on SP Platform to Capture Rising ASC Procedure Volume

Intuitive Surgical's SP platform is gaining traction as a cost-efficient, high-throughput option for ASCs, complementing da Vinci 5 in hospitals.

Intuitive expands AI and advanced imaging integration in Ion Endoluminal System

FDA-cleared software release enhances navigation and broadens access to advanced imaging for lung biopsy procedures FDA-cleared software release enhances navigation and broadens access to advanced imaging for lung biopsy procedures

Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?

Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

ISRG Expands SP Indications: A Game Changer in Colorectal Surgery?

Intuitive Surgical's SP platform secures new colorectal clearances, with 88% growth in procedures and rising global adoption momentum.

Is Intuitive Surgical the Hidden Winner in Healthcare's Weakness?

The medical sector in the United States has been heavily affected by a bearish cycle, driven by scandals surrounding the GLP-1 drugs used in weight loss solutions for consumers. As more companies are exposed to the manufacturing and distribution of these drugs, even some unrelated names have been dragged down by this broader sentiment, creating massive opportunities for those who are bold enough to look into the space.

ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?

The robotic surgery market is undergoing rapid transformation, driven by technological advancements, increasing adoption in hospitals, and a shift toward minimally invasive procedures. As of 2025, it's growing rapidly, focusing on precision, AI integration, and expanding its use across specialties like urology, gynecology, orthopedics, and general surgery.

Is Most-Watched Stock Intuitive Surgical, Inc. (ISRG) Worth Betting on Now?

Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

ISRG SP Platform's Expansion in Korea and Europe Gains Traction

Intuitive Surgical's SP platform gains momentum with 112% growth in Korea and steady European uptake, highlighting global adoption despite regional headwinds.

Intuitive Surgical Stock Is Trading Near Its 52-Week Low. Could This Be a No-Brainer Buy for the Long Haul?

Intuitive Surgical (ISRG 0.19%) makes surgical systems that are transforming the healthcare industry, making it easier for surgeons to conduct difficult surgeries. And that can increase success rates in surgery and improve outcomes from patients.

ISRG Stock Dips Despite Introducing Real-Time Insights on da Vinci 5

Intuitive Surgical unveils real-time surgical insights on its da Vinci 5, enhancing precision, safety, and efficiency with advanced software features.

ISRG Stock Down More than 13% in 3 Months: How to Play the Stock?

Intuitive Surgical shares are down 13% in three months as margin pressures weigh on the stock, but strong procedure growth keeps its long-term story intact.

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know

Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Intuitive Introduces Real-Time Surgical Insights for da Vinci 5

SUNNYVALE, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the first in a series of new software capabilities for da Vinci 5, designed to enhance surgeon and hospital efficiency through the delivery of a range of real-time surgical insights.

Wall Street Bulls Look Optimistic About Intuitive Surgical (ISRG): Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Ion Platform Poised for Cost Optimization: A Margin Lever for ISRG?

Intuitive Surgical's Ion platform is driving rapid growth, but cost optimization could be the key to turning it from a margin drag to a margin lever.

MemorialCare Launches Da Vinci 5 Robotic Surgical System, Expanding Robotic Surgical Program Access Across All Hospitals in Health System

Next-generation technology enhances precision, improves patient outcomes, and expands minimally invasive surgery across Long Beach, Fountain Valley and Laguna Hills. FOUNTAIN VALLEY, Calif.

Intuitive Surgical: What's Happening With ISRG Stock?

Intuitive Surgical stock (NASDAQ: ISRG) has dropped 16% this year, notably lagging behind the S&P 500's 10% increase. The stock has experienced downward pressure recently after management indicated that potential tariffs may adversely affect its performance in 2026.

Intuitive Surgical, Inc. (ISRG) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Intuitive Surgical, Inc. (NASDAQ:ISRG ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 9:30 AM EDT Company Participants David Rosa - CEO & Director Jamie Samath - CFO, Head of Business Technology & Enterprise Technology Leader Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst All right. Good morning, everyone.

The Best Home Run Growth Stocks To Buy Today

ISRG's SP Stapler: A Game Changer for Colorectal and Thoracic Procedures?

Intuitive Surgical's new SP stapler opens doors to colorectal and thoracic surgeries, potentially transforming the single-port platform's adoption curve.

Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It

Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

ISRG vs. MDT: Which MedTech Titan Is the Stronger Investment Choice Now?

ISRG's strong double-digit robotic growth stands in contrast to MDT's diversified portfolio and more attractive valuation, setting up a compelling medtech comparison.

SP Platform's 88% Procedure Growth: The Next Frontier for ISRG?

Intuitive Surgical's SP platform posts 88% procedure growth in Q2, driven by a 112% surge in Korea and expanding adoption in colorectal and thoracic surgery.

Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?